AIDS research and therapy · 2026
Antinuclear antibody (ANA) screening based on EULAR/ACR 2019 clinical domain criteria among PLHIV and profile of diagnosed HIV-SLE cases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chakravarty Jaya, Chaubey Manaswi, Seth Amartya, Rai Thakur Shubh Narayan, Debuka Aditya, Gupta Ajay, Naidu P Raviteja
Аннотация
Systemic lupus erythematosus (SLE) in people living with HIV (PLHIV) is rare, with limited prevalence data. We performed symptom-directed antinuclear antibody (ANA) screening in 129 PLHIV, followed by extractable nuclear antigen testing in ANA-positive individuals. SLE was diagnosed using the 2019 ACR-EULAR criteria. ANA positivity was seen in 54 patients, while anti-dsDNA antibodies were detected in four, all diagnosed with SLE. Three patients were male, with polyarthritis as the most common presentation, followed by proteinuria. Sjögren syndrome, dermatomyositis, and primary systemic sclerosis were identified in one patient each. A literature review identified 165 reported cases of HIV-associated SLE, 93 reported between 2014 and 2024.